Alyeska Investment Group’s 4D Molecular Therapeutics FDMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-113,590
Closed -$3.62M 540
2024
Q1
$3.62M Buy
+113,590
New +$3.62M 0.02% 338